VEEV
Veeva Systems Inc.
NYSEUSDEQUITY
Healthcare
DELAYED
Buy
+54/100
Last price
283.53
▲ 0.08 (0.03%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
285.90
Prev close
283.45
Day high
289.87
Day low
282.26
Volume
1.17M
Market cap
$45.90B
P/E (TTM)
46.48
52W range
148.05 – 308.36
Day trading desk
Gap from prior close
+0.86%
Prior close 283.45
VWAP
284.16
-0.22% from price
Relative volume
1.52×
Unusually busy
Session range
2.70%
282.26 – 289.87
Position in range
17%
Near session low
ATR (14D)
8.45
2.98% of price
Prior day high
283.47
PDH
Prior day low
274.00
PDL
Bid / ask spread
—
Quote not published
Session volume
2.56M
Avg 1.69M
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
+1.77%
-0.2%
1M
+3.06%
+1.9%
3M
+50.66%
+46.1%
6M
+64.33%
+46.1%
YTD
+27.00%
+12.7%
1Y
-4.31%
-20.7%
3Y
+39.35%
-42.9%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
16 more panels on VEEV open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
+7.42K
Net buying
Buy transactions
27
66.51K shares
Sell transactions
8
59.09K shares
Net transactions
+35
Buys less sells
Sell : buy shares
0.9 : 1
Mixed
Insider-held shares
13.96M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Oct 2, 26 | RIZZO DANIEL J Officer |
SELL | 4.84K | $1.34M | Direct |
| Oct 1, 26 | ZUPPAS ELENI NITSA A President |
— | 2.18K | — | Direct |
| Oct 1, 26 | SCHWENGER THOMAS D President |
— | 2.91K | — | Direct |
| Oct 1, 26 | KONDATH VIPIN Officer |
— | 168 | — | Direct |
| Oct 1, 26 | RIZZO DANIEL J Officer |
— | 1.67K | — | Direct |
| Sep 14, 26 | SCHWENGER THOMAS D President |
SELL | 1.00K | $265.20K | Direct |
| Sep 9, 26 | HUNG PRISCILLA C Director |
SELL | 750 | $195.78K | Direct |
| Sep 1, 26 | RITTER GORDON Director |
— | 541 | — | Direct |
| Sep 1, 26 | MOHR MARSHALL L Director |
— | 525 | — | Direct |
| Sep 1, 26 | HEDLEY MARY LYNNE Director |
— | 477 | — | Direct |
| Sep 1, 26 | CARGES MARK T Director |
— | 493 | — | Direct |
| Sep 1, 26 | SEKHRI PAUL JAI Director |
— | 460 | — | Direct |
| Sep 1, 26 | WALLACH MATTHEW J Director |
— | 460 | — | Direct |
| Sep 1, 26 | CABRAL TIMOTHY S Director |
— | 477 | — | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
CARGES MARK T |
Director | 13.45K | Conversion of Exercise of derivative security |
FADDIS JONATHAN W |
General Counsel | 9.33K | Conversion of Exercise of derivative security |
HEDLEY MARY LYNNE |
Director | 7.63K | Conversion of Exercise of derivative security |
RITTER GORDON |
Director | 934.30K | Conversion of Exercise of derivative security |
RIZZO DANIEL J |
Officer | 7.67K | Sale |
SCHWENGER THOMAS D |
President | 20.08K | Conversion of Exercise of derivative security |
SEKHRI PAUL JAI |
Director | 15.65K | Conversion of Exercise of derivative security |
VAN WAGENER BRIAN |
Chief Financial Officer | 9.32K | Conversion of Exercise of derivative security |
WALLACH MATTHEW J |
Director | 357.39K | Conversion of Exercise of derivative security |
ZUPPAS ELENI NITSA A |
President | 34.49K | Conversion of Exercise of derivative security |
Fundamentals
Market cap$45.90B
Enterprise value$38.81B
Revenue (TTM)$3.46B
Gross profit$2.59B
EBITDA$1.08B
Net income$1.01B
EPS (TTM)$6.10
Free cash flow$1.26B
Total cash$7.24B
Total debt$151.70M
Book value / share$44.83
Shares outstanding161.91M
Float148.28M
Short % of float3.35%
Dividend yield0.00%
Beta (5Y)0.93
Valuation & profitability ratios
Trailing P/E46.48
Forward P/E27.66
PEG ratio1.09
Price / sales—
Price / book6.32
EV / revenue11.22
EV / EBITDA36.09
Gross margin74.96%
Operating margin29.64%
Profit margin29.34%
Return on equity14.42%
Return on assets7.58%
Debt / equity2.04
Current ratio5.46
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2026 | 2025 | 2024 | 2023 | YoY |
|---|---|---|---|---|---|
| Total revenue | $3.20B | $2.75B | $2.36B | $2.16B | +16.3% |
| Operating revenue | $3.20B | $2.75B | $2.36B | $2.16B | +16.3% |
| Cost of revenue | $782.02M | $699.64M | $677.29M | $609.40M | +11.8% |
| Gross profit | $2.41B | $2.05B | $1.69B | $1.55B | +17.9% |
| Research & development | $767.39M | $693.08M | $629.03M | $520.28M | +10.7% |
| Selling, general & admin | $729.54M | $662.47M | $628.02M | $566.29M | +10.1% |
| Total operating expense | $1.50B | $1.36B | $1.26B | $1.09B | +10.4% |
| Operating income | $916.37M | $691.43M | $429.33M | $459.09M | +32.5% |
| Net interest income | $267.22M | $207.99M | $133.75M | $45.86M | +28.5% |
| Pre-tax income | $1.19B | $919.38M | $588.02M | $509.10M | +29.9% |
| Tax provision | $285.60M | $205.24M | $62.32M | $21.39M | +39.2% |
| Net income | $908.91M | $714.14M | $525.71M | $487.71M | +27.3% |
| Net income to common | $908.91M | $714.14M | $525.71M | $487.71M | +27.3% |
| Basic EPS | 5.55 | 4.41 | 3.27 | 3.14 | +25.9% |
| Diluted EPS | 5.44 | 4.32 | 3.22 | 3.00 | +25.9% |
| EBIT | $916.37M | $691.43M | $429.33M | $459.09M | +32.5% |
| EBITDA | $954.34M | $730.82M | $461.96M | $488.21M | +30.6% |
| Basic shares | 163.67M | 161.88M | 160.53M | 155.38M | +1.1% |
| Diluted shares | 167.00M | 165.23M | 163.49M | 162.44M | +1.1% |
| Line item | 2026 | 2025 | 2024 | 2023 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $1.42B | $1.12B | $703.49M | $886.47M | +27.0% |
| Cash & short-term investments | $6.56B | $5.15B | $4.03B | $3.10B | +27.4% |
| Accounts receivable | $1.26B | $1.02B | $852.17M | $703.05M | +23.9% |
| Total current assets | $8.00B | $6.31B | $5.00B | $3.97B | +26.8% |
| Property, plant & equipment | $145.89M | $119.78M | $104.13M | $105.15M | +21.8% |
| Goodwill & intangibles | $470.19M | $484.34M | $502.89M | $522.35M | -2.9% |
| Total assets | $8.98B | $7.34B | $5.91B | $4.80B | +22.3% |
| Total current liabilities | $1.64B | $1.40B | $1.18B | $1.01B | +17.1% |
| Total debt | $95.86M | $75.78M | $55.77M | $60.98M | +26.5% |
| Total liabilities | $1.76B | $1.51B | $1.27B | $1.09B | +17.1% |
| Retained earnings | $4.36B | $3.45B | $2.74B | $2.21B | +26.3% |
| Shareholder equity | $7.21B | $5.83B | $4.64B | $3.72B | +23.7% |
| Working capital | $6.36B | $4.91B | $3.82B | $2.96B | +29.5% |
| Net tangible assets | $6.74B | $5.35B | $4.14B | $3.19B | +26.1% |
| Shares issued | 163.78M | 162.58M | 161.26M | 158.24M | +0.7% |
| Line item | 2026 | 2025 | 2024 | 2023 | YoY |
|---|---|---|---|---|---|
| Net income | $908.91M | $714.14M | $525.71M | $487.71M | +27.3% |
| Depreciation & amortisation | $37.97M | $39.38M | $32.63M | $29.12M | -3.6% |
| Stock-based compensation | $472.70M | $437.35M | $393.73M | $351.91M | +8.1% |
| Change in working capital | -$91.94M | $7.62M | $60.82M | $7.34M | -1,306.5% |
| Operating cash flow | $1.42B | $1.09B | $911.34M | $780.47M | +29.8% |
| Investing cash flow | -$1.10B | -$700.14M | -$1.08B | -$1.01B | -57.7% |
| Share buybacks | -$169.95M | $0 | $0 | — | — |
| Financing cash flow | -$9.33M | $26.11M | -$16.19M | -$19.38M | -135.7% |
| Free cash flow | $1.42B | $1.09B | $911.34M | $780.47M | +29.8% |
| End cash position | $1.42B | $1.12B | $706.67M | $889.65M | +27.0% |
| Line item | 2026-07-31 | 2026-04-30 | 2026-01-31 | 2025-10-31 | 2025-07-31 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $927.96M | $882.95M | $835.95M | $811.24M | $789.08M | +5.1% |
| Operating revenue | $927.96M | $882.95M | $835.95M | $811.24M | $789.08M | +5.1% |
| Cost of revenue | $232.01M | $220.92M | $213.48M | $199.47M | $195.25M | +5.0% |
| Gross profit | $695.95M | $662.02M | $622.47M | $611.77M | $593.83M | +5.1% |
| Research & development | $222.92M | $208.32M | $198.79M | $191.88M | $192.68M | +7.0% |
| Selling, general & admin | $198.01M | $180.59M | $177.81M | $179.03M | $205.24M | +9.6% |
| Total operating expense | $420.93M | $388.91M | $376.60M | $370.92M | $397.92M | +8.2% |
| Operating income | $275.02M | $273.11M | $245.88M | $240.85M | $195.91M | +0.7% |
| Pre-tax income | $349.53M | $347.53M | $317.54M | $312.79M | $265.36M | +0.6% |
| Tax provision | $76.10M | $86.59M | $73.33M | $76.58M | $65.06M | -12.1% |
| Net income | $273.43M | $260.94M | $244.20M | $236.20M | $200.31M | +4.8% |
| Net income to common | $273.43M | $260.94M | $244.20M | $236.20M | $200.31M | +4.8% |
| Basic EPS | 1.68 | 1.60 | 1.49 | 1.44 | 1.23 | +5.0% |
| Diluted EPS | 1.66 | 1.57 | 1.45 | 1.40 | 1.19 | +5.7% |
| EBIT | $275.02M | $273.11M | $245.88M | $240.85M | $195.91M | +0.7% |
| EBITDA | $285.89M | $284.70M | $254.19M | $250.56M | $206.03M | +0.4% |
| Basic shares | 162.34M | 163.34M | 164.34M | 164.05M | 163.50M | -0.6% |
| Diluted shares | 165.06M | 165.99M | 168.26M | 168.94M | 167.69M | -0.6% |
| Line item | 2026-07-31 | 2026-04-30 | 2026-01-31 | 2025-10-31 | 2025-07-31 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $1.81B | $1.90B | $1.42B | $1.66B | $1.93B | -4.5% |
| Cash & short-term investments | $7.24B | $7.31B | $6.56B | $6.64B | $6.40B | -1.0% |
| Accounts receivable | $496.68M | $568.02M | $1.26B | $314.23M | $422.07M | -12.6% |
| Total current assets | $7.95B | $8.06B | $8.00B | $7.11B | $6.99B | -1.5% |
| Property, plant & equipment | $208.80M | $155.54M | $145.89M | $139.96M | $132.75M | +34.2% |
| Goodwill & intangibles | $548.64M | $543.67M | $470.19M | $472.53M | $476.32M | +0.9% |
| Total assets | $9.06B | $9.13B | $8.98B | $8.10B | $8.00B | -0.8% |
| Total current liabilities | $1.46B | $1.70B | $1.64B | $944.88M | $1.26B | -14.4% |
| Total debt | $151.69M | $103.07M | $95.86M | $89.80M | $85.45M | +47.2% |
| Total liabilities | $1.63B | $1.83B | $1.76B | $1.06B | $1.36B | -10.8% |
| Retained earnings | $4.90B | $4.62B | $4.36B | $4.12B | $3.88B | +5.9% |
| Shareholder equity | $7.43B | $7.30B | $7.21B | $7.04B | $6.64B | +1.7% |
| Working capital | $6.49B | $6.36B | $6.36B | $6.17B | $5.74B | +2.0% |
| Net tangible assets | $6.88B | $6.76B | $6.74B | $6.57B | $6.16B | +1.8% |
| Shares issued | 161.83M | 162.94M | 163.78M | 164.34M | 163.88M | -0.7% |
| Line item | 2026-07-31 | 2026-04-30 | 2026-01-31 | 2025-10-31 | 2025-07-31 | 2025-04-30 | YoY |
|---|---|---|---|---|---|---|---|
| Net income | $273.43M | $260.94M | $244.20M | $236.20M | $200.31M | — | +4.8% |
| Depreciation & amortisation | $10.87M | $11.59M | $8.32M | $9.71M | $10.13M | — | -6.2% |
| Stock-based compensation | $136.80M | $119.26M | $118.26M | $120.27M | $121.97M | — | +14.7% |
| Change in working capital | -$202.85M | $716.38M | -$286.93M | -$197.71M | -$152.53M | — | -128.3% |
| Operating cash flow | $238.71M | $1.13B | $106.85M | $192.79M | $238.43M | — | -78.8% |
| Investing cash flow | -$63.54M | -$388.71M | -$167.75M | -$495.23M | -$389.27M | — | +83.7% |
| Share buybacks | -$245.73M | -$226.95M | — | — | $0 | $0 | -8.3% |
| Financing cash flow | -$259.31M | -$262.53M | -$178.05M | $32.65M | $115.69M | — | +1.2% |
| Free cash flow | $238.71M | $1.13B | $106.85M | $192.79M | $238.43M | — | -78.8% |
| End cash position | $1.81B | $1.90B | $1.42B | $1.66B | $1.93B | — | -4.4% |
Options analytics
Put / call volume
0.61
Call-heavy session
Put / call open interest
0.42
Positioning, not flow
Max pain
270.00
-4.8% from spot
ATM implied vol
49.2%
Nearest strike to spot
Skew (10% OTM)
-6.2%
Calls bid over puts
Call volume
224
Contracts, this expiry
Put volume
137
Contracts, this expiry
Heaviest call OI
310.00
810 contracts
Heaviest put OI
240.00
250 contracts
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jul 2026 | 2.22 | 2.35 | +5.8% |
| Apr 2026 | 2.14 | 2.24 | +4.9% |
| Jan 2026 | 1.94 | 2.06 | +6.5% |
| Oct 2025 | 1.95 | 2.04 | +4.6% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | 2.34 | 26 | $934.98M | +15.3% |
| Next quarter | 2.31 | 26 | $943.97M | +12.9% |
| Current year | 9.24 | 27 | $3.69B | +15.5% |
| Next year | 10.25 | 26 | $4.14B | +12.3% |
Analyst targets & ownership
Mean target$297.30
High target$350.00
Low target$180.00
Implied upside4.86%
Analyst count27
ConsensusBUY
Strong buy / Buy8 / 12
Hold8
Sell / Strong sell1 / 0
Held by insiders8.62%
Held by institutions93.31%
Institutions holding1.55K
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
279.25
+1.53% from price
SMA 20
271.00
+4.61% from price
SMA 50
254.46
+11.41% from price
SMA 100
214.54
+32.16% from price
SMA 200
201.89
+40.43% from price
EMA 12
277.16
+2.30% from price
EMA 26
269.35
+5.26% from price
EMA 50
253.55
+11.82% from price
RSI (14)
62.4
Neutral
MACD (12,26,9)
7.81
Hist -0.17
ATR (14)
8.45
2.98% of price
Realised vol 30D
50.2%
Annualised
Bollinger upper
288.99
20, 2σ
Bollinger lower
253.01
20, 2σ
50 / 200 cross
Golden
254.46 vs 201.89
Trend bias
Above 200
+40.43%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
0.56
Less volatile than market
Correlation to SPY
0.17
Largely independent
Realised vol 30D
50.2%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-50.5%
Peak to trough
Max drawdown 5Y
-53.5%
Peak to trough
ATR 14
8.45
2.98% of price
Beta (reported)
0.93
5Y monthly, from filing
Short interest
Shares short
4.96M
Prior 5.84M
Change vs prior
-15.1%
Shorts covering
% of float
3.35%
Normal
% of shares out
3.07%
Against total outstanding
Days to cover
2.9
Liquid
Float
148.28M
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 28, 26 | Citigroup | MAINTAINED | Neutral | Neutral |
| Aug 27, 26 | Mizuho | MAINTAINED | Outperform | Outperform |
| Aug 27, 26 | BMO Capital | MAINTAINED | Market Perform | Market Perform |
| Aug 27, 26 | Baird | MAINTAINED | Outperform | Outperform |
| Aug 27, 26 | Canaccord Genuity | MAINTAINED | Hold | Hold |
| Aug 27, 26 | TD Cowen | MAINTAINED | Buy | Buy |
| Aug 27, 26 | Barclays | MAINTAINED | Overweight | Overweight |
| Aug 27, 26 | UBS | MAINTAINED | Neutral | Neutral |
| Aug 27, 26 | RBC Capital | MAINTAINED | Outperform | Outperform |
| Aug 27, 26 | Guggenheim | MAINTAINED | Buy | Buy |
| Aug 27, 26 | Morgan Stanley | MAINTAINED | Equal-Weight | Equal-Weight |
| Aug 27, 26 | Truist Securities | MAINTAINED | Buy | Buy |
Dividends & splits
Forward rate—
Forward yield0.00%
5-year avg yield—
Payout ratio0.00%
Ex-dividend date—
Next pay date—
Last split—
Split date—
SEC filings
Corporate Changes & Voting Matters
8-K · 2026-08-26
Corporate Changes & Voting Matters
8-K · 2026-08-20
Corporate Changes & Voting Matters
8-K · 2026-06-18
Periodic Financial Reports
10-Q · 2026-06-05
Corporate Changes & Voting Matters
8-K · 2026-06-03
Annual Report to Shareholders
ARS · 2026-05-04
Corporate Changes & Voting Matters
8-K · 2026-04-20
Offering Registrations
S-8 · 2026-03-20
Headlines
Sector Update: Healthcare Stocks Rise Premarket Tuesday
MT Newswires · 14h ago
Veeva Says DQS System Has Cleaned Data for More Than 1 Million Clinical Trial Subjects
MT Newswires · 15h ago
Veeva DQS Cleans Data for More Than 1 Million Subjects Across Over 1,000 Studies
PR Newswire · 16h ago
Veeva's OpenData to Help Servier Build a Global AI Data Foundation
Zacks · 1d ago
Company News for Oct 5, 2026
Zacks · 2d ago
Veeva Systems (VEEV) Stock Sinks As Market Gains: What You Should Know
Zacks · 4d ago
Veeva Systems (VEEV) Stock Declines While Market Improves: Some Information for Investors
Zacks · 5d ago
AI Will Revolutionize Medicine. This Company Provides the Plumbing.
Barrons.com · 5d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.